SCHEMBL10323719

SCHEMBL10323719

O=C(O)NC1CCC(Nc2ncc3cc(C(=O)N(Cl)c4cccc(C(=O)NCc5cccc(Cl)c5)c4)c(=O)[nH]c3n2)CC1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 6/20 0.49
▸ DYRK1B Q9Y463 6/20 0.49
▸ MCHR1 Q99705 3/20 0.39
▸ ADRA2A P08913 2/20 0.39
▸ MAPK1 P28482 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ ADRA1A P35348 1/20 0.37
▸ HRH1 P35367 1/20 0.37
▸ HTR2B P41595 1/20 0.37
▸ ROCK2 O75116 1/20 0.37
▸ ROCK1 Q13464 1/20 0.37
▸ TYRO3 Q06418 1/20 0.36
▸ VNN1 O95497 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ HCRTR1 O43613 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ CNR2 P34972 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10323718 0.86 DYRK1A (0.68) DYRK1ADYRK1B
SCHEMBL10323717 0.86 DYRK1A (0.68) DYRK1ADYRK1B
SCHEMBL10324084 0.85 DYRK1A (0.48) DYRK1ADYRK1BMAPK1LMNASMN1; SMN2
SCHEMBL10324514 0.81 DYRK1A (0.49) DYRK1ADYRK1BNPC1LMNAROCK2
SCHEMBL10446550 0.79 DYRK1A (0.69) DYRK1ADYRK1B
SCHEMBL10446551 0.79 DYRK1A (0.69) DYRK1ADYRK1B
SCHEMBL10323240 0.79 DYRK1A (0.47) DYRK1ADYRK1BLMNASMN1; SMN2
SCHEMBL10446987 0.78 DYRK1A (0.68) DYRK1ADYRK1B
Hydrochloric Acid SCHEMBL10322306 0.78 DYRK1A (0.68) DYRK1ADYRK1B
Hydrochloric Acid SCHEMBL10322304 0.78 DYRK1A (0.68) DYRK1ADYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120184542-A1 PYRIDO PYRIMIDINES ANDERSON KEVIN (US) 2012-07-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184542-A1 PYRIDO PYRIMIDINES TYMS, TYMP, DPYD DYRK1A 654/4885DYRK1B 570/4885MCHR1 4824/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback